Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Intensive BP Treatment & Subsequent CVD Risk

J Am Coll Cardiol; ePub 2018 Mar 7; Phillips, et al

Individuals with lower baseline cardiovascular disease (CVD) risk had more harm than benefit from intensive treatment of hypertension, while those with higher risk had more benefit. This according to a study that examined the effect of baseline 10-year CVD risk on primary outcome events and all-cause serious adverse events (SAEs) in the Systolic Pressure Intervention Trial (SPRINT). Stratifying by quartiles of baseline 10-year CVD risk, Cox proportional hazards models were used to examine the associations of treatment group with primary outcomes events and SAEs. Researchers found:

  • Within each quartile, there was a lower rate of primary outcome vents in the intensive treatment group, with no differences in all-cause SAEs.
  • The number needed to treat to prevent primary outcomes decreased from 91 to 30 from the first to fourth quartiles.
  • The number need to harm for all-cause SAEs increased from 62 to 250.
  • There was significantly increasing benefit-to-harm ratio for the first, second, third, and fourth quartile, respectively.

Citation:

Phillips R, Xu J, Peterson LE, et al. Impact of cardiovascular risk on the relative benefit and harm of intensive treatment of hypertension. [Published online ahead of print March 7, 2018]. J Am Coll Cardiol. doi:10.1016/j.jacc.2018.01.074.

This Week's Must Reads

AHA Statement on Promotion of Physical Activity, Circulation; ePub 2018 Apr 4; Lobelo, et al

CVD & Risk Management in ADA Guidelines, Ann Intern Med; ePub 2018 Apr 3; Chamberlain, et al

Diabetes and Trends in Perioperative CV Events, Diabetes Care; ePub 2018 Apr 4; Newman, et al

Medical Cannabis Laws and Opioid Prescribing, JAMA Intern Med; ePub 2018 Apr 2; Bradford, et al

Evaluating Vaccination Strategies for Zika Virus, Ann Intern Med; ePub 2018 Apr 3; Durham, et al

Must Reads in Cardiology

AHA Statement on Promotion of Physical Activity, Circulation; ePub 2018 Apr 4; Lobelo, et al

CVD & Risk Management in ADA Guidelines, Ann Intern Med; ePub 2018 Apr 3; Chamberlain, et al

Diabetes and Trends in Perioperative CV Events, Diabetes Care; ePub 2018 Apr 4; Newman, et al

Cardiorespiratory Fitness & All-Cancer Mortality, Mayo Clin Proc; ePub 2018 Mar 27; Wang, et al

Disparities in Heart Disease Death Rates, MMWR; 2018 Mar 30; Van Dyke, Greer, et al